Teva Pharmaceutical Appoints Chen Lichtenstein to Board of Directors

Summary

On November 5, 2024, Teva Pharmaceutical Industries Ltd. announced the appointment of Mr. Chen Lichtenstein as a new member of its Board of Directors, effective December 1, 2024. Mr. Lichtenstein, an experienced executive with a background in agricultural technology and global operations, brings extensive leadership and strategic expertise to the board. He is set to receive the same compensation as Teva's other non-executive directors.